Polaris Market Research presents its latest market research report, titled Iliac Stent Market Size, Share, Growth Analysis Report, 2024-2032. It is a comprehensive market research report analyzing the fast-evolving Iliac Stent market. The report offers insight into the current market landscape, drivers for growth, emerging trends, competitive dynamics, and future scope for growth. The study is a combination of qualitative and quantitative analysis, giving insights about the size of the market, segments, regional performance, and industry developments. By going through the report, stakeholders can get an in-depth overview of the Iliac Stent market and its outlook during the forecast period.
Iliac Stent Market Key Takeaways
- The Iliac Stent market size was valued at USD 1,047.21 million in 2023.
- The market is estimated to reach USD 1,708.54 million by 2032.
- The market is projected to witness a CAGR of 5.6% from 2024 to 2032.
- The self-expandable stents segment accounted for the largest share of the market in 2023.
- The complete obstructive lesions segment is likely to grow at a strong pace during the forecast period.
- The North America region held the largest share of market in 2023.
- Asia Pacific region is expected to grow at a significant CAGR from 2024 to 2032.
What is Iliac Stent Market?
The Iliac Stent market covers devices used in minimally invasive procedures to treat narrowed or blocked iliac arteries, restoring healthy blood flow to the lower limbs. These self-expandable, balloon-expandable, and covered stents are placed via angioplasty to manage peripheral artery disease, supporting patients across hospitals and ambulatory surgical centers worldwide.
Market Dynamics
The report examines the key market dynamics influencing the growth and development of the Iliac Stent market. It analyzes the market drivers, market opportunities, market trends, and restraints that might impact the growth of the market.
Key Market Driver: Rising Prevalence of Peripheral Artery Disease
The growing global incidence of peripheral artery disease, particularly among aging populations, is a key driver of the Iliac Stent market. Sedentary lifestyles, obesity, smoking, and rising diabetes rates are contributing to more cases of narrowed iliac arteries. As awareness of minimally invasive endovascular treatment options grows, demand for iliac stenting procedures that restore circulation and relieve symptoms such as claudication continues to climb, especially across high-income regions with older populations.
Market Opportunity: Next-Generation Stent Technologies
Advances in stent design are opening new growth avenues for the Iliac Stent market. Manufacturers are investing in drug-eluting coatings that limit restenosis, bioresorbable platforms that provide temporary vascular support before dissolving, and improved Nitinol-based designs offering better flexibility and radial strength. These innovations, aimed at improving biocompatibility and reducing thrombosis risk, create opportunities for companies to differentiate their offerings and capture share in an increasingly technology-driven treatment landscape.
Emerging Market Trend: New Product Approvals and Launches
A steady stream of regulatory approvals and product launches is shaping the Iliac Stent market. Recent examples include Getinge's FDA-cleared iCast covered stent system for iliac artery occlusive disease, and Gore's lower-profile Viabahn VBX stent graft, which simplifies access for physicians managing complex lesions. Companies are also entering distribution partnerships to widen commercial reach, reflecting a trend toward broader device availability and faster adoption of covered and self-expanding stent options.
Market Challenge: Limited Awareness and Underdiagnosis
Low awareness and underdiagnosis of peripheral artery disease among both patients and healthcare providers remain a challenge for the Iliac Stent market. The condition often shows no symptoms or mild signs in its early stages, causing it to be mistaken for normal aging or other illnesses. As a result, many patients go undiagnosed until the disease progresses, delaying intervention. Healthcare disparities in underserved communities with limited access to care further compound this underdiagnosis problem.
𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :
https://www.polarismarketresearch.com/industry-analysis/iliac-stent-market
How Is Market Segmentation Done?
The research gives an in-depth segmental analysis of the Iliac Stent industry. The segmentation in the market has been done on the basis of type, artery lesions, and end use. By type, the market is classified into self-expandable stents, balloon-expandable stents, and others. By artery lesions, it is segmented into common iliac artery lesions, severe calcified lesions, and complete obstructive lesions. By end use, the market covers hospitals, ambulatory surgical centers, and others. This research assesses the contribution of each segment and pinpoints the segments driving the present-day demand and those that will grow strongly during the forecast period. This analysis helps stakeholders analyze evolving demand trends and recognize promising market opportunities.
Which Region Leads Market Demand?
The report includes a regional analysis of the Iliac Stent market, covering North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market dominates the overall market, attributed to a growing elderly population, rising rates of obesity and diabetes, expanding R&D investment in innovative treatments, and increasing awareness of peripheral artery disease. Further, the Asia Pacific market is expected to witness significant growth during the forecast period, influenced by a rising elderly population, growing incidence of cardiovascular illnesses, and ongoing improvements in minimally invasive surgical techniques across countries such as China and Japan. In addition to this, there is an analysis of regional demand, investments, infrastructure, regulatory environment, technology penetration, and industry development.
Who Are the Key Market Players?
The report presents a detailed competitive analysis of the Iliac Stent industry. Player positioning and their strategy, such as new product/service launches, partnerships, mergers and acquisitions, geographic expansion, capacity expansion, technological developments, etc., have been analyzed. The report also examines the competitive structure of the industry and how organizations are responding to changing consumer demands.
A few of the key players in the market include:
- Abbott
- BD
- Biotronik SE & Co KG
- Boston Scientific Corporation
- Cook
- Getinge AB
- iVascular
- Medtronic
- Terumo Corporation
- L. Gore & Associates, Inc.
Future Outlook
The Iliac Stent market is projected to grow and evolve until the forecast year 2032 as demand grows, applications widen, and industry players respond to changing demands. Innovations, investments, and technological advancements are expected to drive market development and present new opportunities in major segments and geographies. This report provides insights into how the market is expected to evolve, thereby enabling stakeholders to understand opportunities and developments likely to shape the market during the forecast period.
More Trending Latest Reports By Polaris Market Research:
automated-teller-machine-atm-market
global-organic-skin-care-market